cache/7ba60bf3a2ed401cc49c375055c2c2d2845b156d9190a5caf9fa20677a98bb56

COM:AMOLYTPHARMA

Amolyt Pharma

  • Privately Held

Amolyt Pharma is a biopharmaceutical company focused on developing treatments for hypoparathyroidism, a rare endocrine disorder. The company is developing eneboparatide, a novel parathyroid hormone receptor 1 (PTHR1) agonist, which has demonstrated promising results in clinical trials.

investor of